Breaking News Instant updates and real-time market news.

IDXG

Interpace Biosciences

$0.76

-0.0178 (-2.29%)

07:15
11/04/19
11/04
07:15
11/04/19
07:15

Interpace announces publication of two peer-reviewed articles on ThyGeNEXT

Interpace Group Interpace Diagnostics announced the publication of two peer-reviewed journal articles and one textbook chapter supporting the clinical utility of ThyGeNEXT when used alone and in combination with ThyraMIR. The most recent article was published in Diagnostic Cytopathology in a paper called "Incremental Utility of Expanded Mutation Panel When Used in Combination with MicroRNA Classification in Indeterminate Thyroid Nodules". An independent peer-reviewed journal article has been published in the Journal of Otolaryngology related to a study lead by Dr. Rick Payne from McGill University, Montreal, QC, Canada.

IDXG Interpace Biosciences
$0.76

-0.0178 (-2.29%)

09/25/19
OPCO
09/25/19
INITIATION
Target $3
OPCO
Outperform
Interpace Diagnostics initiated with an Outperform at Oppenheimer
Oppenheimer analyst Kevin DeGreeter initiated Interpace Diagnostics with an Overweight and $3 price target.
09/25/19
OPCO
09/25/19
INITIATION
Target $3
OPCO
Outperform
Oppenheimer starts Interpace at Outperform, sees 'clear path to BioPharma'
As previously reported, Oppenheimer analyst Kevin DeGreeter initiated Interpace Diagnostics with an Overweight rating and $3 price target, stating that he views it as an "emerging growth story in the oncology diagnostics space." The company recently entered a new high growth market with the acquisition of a BioPharma testing business, it continues to secure improved payor coverage for its ThyGeNEXT and ThyraMIR tests and it has a strategic investor that may support additional business development, the analyst stated.Target $3.

TODAY'S FREE FLY STORIES

AKZOY

AkzoNobel

$0.00

(0.00%)

06:30
12/12/19
12/12
06:30
12/12/19
06:30
Upgrade
AkzoNobel rating change  »

AkzoNobel upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CGNX

Cognex

$52.45

1.51 (2.96%)

06:30
12/12/19
12/12
06:30
12/12/19
06:30
Initiation
Cognex initiated  »

Cognex initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COLD

Americold Realty Trust

$35.03

-0.66 (-1.85%)

, INVH

Invitation Homes

$29.46

-0.42 (-1.41%)

06:29
12/12/19
12/12
06:29
12/12/19
06:29
Recommendations
Americold Realty Trust, Invitation Homes analyst commentary  »

Citi adds Americold…

COLD

Americold Realty Trust

$35.03

-0.66 (-1.85%)

INVH

Invitation Homes

$29.46

-0.42 (-1.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WSG

Wanda Sports

$2.82

-0.01 (-0.35%)

06:28
12/12/19
12/12
06:28
12/12/19
06:28
Downgrade
Wanda Sports rating change  »

Wanda Sports downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GKOS

Glaukos

$57.32

-1.895 (-3.20%)

, SPNE

SeaSpine

$12.00

-0.58 (-4.61%)

06:27
12/12/19
12/12
06:27
12/12/19
06:27
Downgrade
Glaukos, SeaSpine, Merit Medical, Medtronic, Teleflex rating change  »

SeaSpine, Glaukos…

GKOS

Glaukos

$57.32

-1.895 (-3.20%)

SPNE

SeaSpine

$12.00

-0.58 (-4.61%)

MMSI

Merit Medical

$29.99

0.69 (2.35%)

MDT

Medtronic

$111.67

0.62 (0.56%)

TFX

Teleflex

$354.93

1.18 (0.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Feb

REG

Regency Centers

$62.65

-1.6 (-2.49%)

06:27
12/12/19
12/12
06:27
12/12/19
06:27
Downgrade
Regency Centers rating change  »

Regency Centers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WRI

Weingarten Realty

$31.03

-0.41 (-1.30%)

06:26
12/12/19
12/12
06:26
12/12/19
06:26
Upgrade
Weingarten Realty rating change  »

Weingarten Realty…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PLCE

Children's Place

$54.36

-16.31 (-23.08%)

06:25
12/12/19
12/12
06:25
12/12/19
06:25
Downgrade
Children's Place rating change  »

Children's Place…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

O

Realty Income

$74.56

-1.08 (-1.43%)

06:24
12/12/19
12/12
06:24
12/12/19
06:24
Upgrade
Realty Income rating change  »

Realty Income upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADC

Agree Realty

$70.90

-1.34 (-1.85%)

06:23
12/12/19
12/12
06:23
12/12/19
06:23
Upgrade
Agree Realty rating change  »

Agree Realty upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VICI

VICI Properties

$24.70

-0.17 (-0.68%)

06:22
12/12/19
12/12
06:22
12/12/19
06:22
Upgrade
VICI Properties rating change  »

VICI Properties upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UDR

UDR, Inc.

$46.80

-0.95 (-1.99%)

06:21
12/12/19
12/12
06:21
12/12/19
06:21
Upgrade
UDR, Inc. rating change  »

UDR, Inc. upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

DOC

Physicians Realty Trust

$18.64

-0.35 (-1.84%)

06:19
12/12/19
12/12
06:19
12/12/19
06:19
Upgrade
Physicians Realty Trust rating change  »

Physicians Realty Trust…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

HR

Healthcare Realty Trust

$32.85

-0.59 (-1.76%)

06:18
12/12/19
12/12
06:18
12/12/19
06:18
Upgrade
Healthcare Realty Trust rating change  »

Healthcare Realty Trust…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,749.00

9.85 (0.57%)

06:18
12/12/19
12/12
06:18
12/12/19
06:18
Periodicals
Amazon sells children's smartwatches that are 'so easy to hack,' BI reports »

Amazon sells…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SFTBF

SoftBank

$0.00

(0.00%)

06:16
12/12/19
12/12
06:16
12/12/19
06:16
Periodicals
SoftBank Vision Fund managing partner to leave company, Business Insider says »

Praveen Akkiraju, a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NBIX

Neurocrine

$113.26

-0.32 (-0.28%)

06:15
12/12/19
12/12
06:15
12/12/19
06:15
Recommendations
Neurocrine analyst commentary  »

Neurocrine price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EXAS

Exact Sciences

$85.16

-0.25 (-0.29%)

06:13
12/12/19
12/12
06:13
12/12/19
06:13
Hot Stocks
Exact Sciences announces new data supporting Oncotype DX Breast Recurrence Score »

Exact Sciences announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

YETI

Yeti

$31.82

1.19 (3.89%)

06:12
12/12/19
12/12
06:12
12/12/19
06:12
Recommendations
Yeti analyst commentary  »

Piper highlights Yeti as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GM

General Motors

$35.23

0.13 (0.37%)

06:12
12/12/19
12/12
06:12
12/12/19
06:12
Hot Stocks
CEO of GM's Cruise unit hints at offering low-cost shared rides »

Dan Ammann, the former…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

WST

West Pharmaceutical

$146.54

1.07 (0.74%)

06:11
12/12/19
12/12
06:11
12/12/19
06:11
Downgrade
West Pharmaceutical rating change  »

West Pharmaceutical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LULU

Lululemon

$233.31

3.75 (1.63%)

06:09
12/12/19
12/12
06:09
12/12/19
06:09
Recommendations
Lululemon analyst commentary  »

Lululemon Q3 beat shows…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INTC

Intel

$57.04

0.43 (0.76%)

, IBM

IBM

$133.81

-0.12 (-0.09%)

06:09
12/12/19
12/12
06:09
12/12/19
06:09
Periodicals
Intel hires former GlobalFoundries CTO Gary Patton, Reuters reports »

Intel (INTC) has hired…

INTC

Intel

$57.04

0.43 (0.76%)

IBM

IBM

$133.81

-0.12 (-0.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

HD

Home Depot

$211.96

-3.88 (-1.80%)

06:06
12/12/19
12/12
06:06
12/12/19
06:06
Downgrade
Home Depot rating change  »

Home Depot downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

JPM

JPMorgan

$134.17

-0.31 (-0.23%)

06:06
12/12/19
12/12
06:06
12/12/19
06:06
Periodicals
JPMorgan to revamp wealth management business, WSJ reports »

JPMorgan is combining its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.